Description

Aspazmin (Mebeverin Hydrochloride) Capsules with Modified Release 200 mg. №30

Ingredients:

Each capsule contains 200 mg of Mebeverin Hydrochloride.

Dosage:

The recommended dosage is one capsule taken orally twice daily, preferably before meals.

Indications:

Aspazmin capsules are indicated for the symptomatic treatment of irritable bowel syndrome (IBS) characterized by abdominal pain, bloating, and altered bowel habits.

Contraindications:

Do not use Aspazmin if you are allergic to Mebeverin Hydrochloride or any other ingredients in the capsules. Consult a healthcare provider before use if pregnant, nursing, or have a history of liver or kidney disease.

Directions:

Swallow the capsule whole with a glass of water. Do not crush or chew the capsule. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence:

Mebeverin Hydrochloride, the active ingredient in Aspazmin, acts as a musculotropic antispasmodic agent in the gastrointestinal tract. It exerts its effects by relaxing smooth muscles, thereby reducing spasms and pain associated with IBS. Clinical studies have demonstrated the efficacy of Mebeverin in improving IBS symptoms such as abdominal discomfort and bloating.

Research published in the “Journal of Gastroenterology” has shown that Mebeverin is well-tolerated and effective in the management of IBS symptoms, making it a valuable treatment option for patients with this condition.

Additional Information:

• Storage: Store Aspazmin capsules in a cool, dry place away from direct sunlight.
• Side Effects: Common side effects may include dizziness, dry mouth, and constipation. If any severe side effects occur, discontinue use and seek medical attention.
• Interactions: Inform your healthcare provider about all medications you are taking, as Mebeverin may interact with certain drugs.